Cargando…
Prostate Cancer Cell Phenotypes Remain Stable Following PDE5 Inhibition in the Clinically Relevant Range
Widespread cGMP-specific phosphodiesterase 5 (PDE5) inhibitor use in male reproductive health and particularly in prostate cancer patients following surgery has generated interest in how these drugs affect the ability of residual tumor cells to proliferate, migrate, and form recurrent colonies. Pros...
Autores principales: | Hankey, William, Sunkel, Benjamin, Yuan, Fuwen, He, Haiyan, Thomas-Ahner, Jennifer M., Chen, Zhong, Clinton, Steven K., Huang, Jiaoti, Wang, Qianben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248418/ https://www.ncbi.nlm.nih.gov/pubmed/32454444 http://dx.doi.org/10.1016/j.tranon.2020.100797 |
Ejemplares similares
-
Molecular determinants for enzalutamide-induced transcription in prostate cancer
por: Yuan, Fuwen, et al.
Publicado: (2019) -
Phosphorylated MED1 links transcription recycling and cancer growth
por: Chen, Zhong, et al.
Publicado: (2022) -
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer
por: Chen, Zhong, et al.
Publicado: (2015) -
Alternative polyadenylation of mRNA and its role in cancer
por: Yuan, Fuwen, et al.
Publicado: (2019) -
Transcription recycling assays identify PAF1 as a driver for RNA Pol II recycling
por: Chen, Zhong, et al.
Publicado: (2021)